$3.03 2.4%
SSKN Stock Price vs. AI Score
Data gathered: November 27

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About STRATA Skin Sciences

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America.


STRATA Skin Sciences
Price $3.03
Target Price Sign up
Volume 11,110
Market Cap $12M
Year Range $2.54 - $5.6
Dividend Yield 0%
Analyst Rating 0% buy
Industry Medical Devices

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '248.8M3.5M5.3M-2.1M-410,000-0.521
Q2 '248.4M3.5M4.9M-99,000760,000-0.030
Q1 '246.8M3.7M3.1M-3.4M-1.6M-0.100
Q4 '238.7M3.9M4.8M-3.8M40,000-0.110
Q3 '238.9M3.9M5M-1.1M200,000-0.030

Insider Transactions View All

Rafaeli Dolev filed to buy 143,156 shares at $3.1.
July 17 '24
Accelmed Growth Partners Management Ltd. filed to buy 1,441,835 shares at $3.1.
July 17 '24
Geiger Uri filed to buy 1,441,835 shares at $3.1.
July 17 '24
Gov Shmuel filed to buy 15,200 shares at $0.5.
December 5 '23
Gov Shmuel filed to buy 14,900 shares at $0.5.
December 5 '23

What is the Market Cap of STRATA Skin Sciences?

The Market Cap of STRATA Skin Sciences is $12M.

What is the current stock price of STRATA Skin Sciences?

Currently, the price of one share of STRATA Skin Sciences stock is $3.03.

How can I analyze the SSKN stock price chart for investment decisions?

The SSKN stock price chart above provides a comprehensive visual representation of STRATA Skin Sciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling STRATA Skin Sciences shares. Our platform offers an up-to-date SSKN stock price chart, along with technical data analysis and alternative data insights.

Does SSKN offer dividends to its shareholders?

As of our latest update, STRATA Skin Sciences (SSKN) does not offer dividends to its shareholders. Investors interested in STRATA Skin Sciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of STRATA Skin Sciences?

Some of the similar stocks of STRATA Skin Sciences are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.